SciSparc (SPRC) Loans - Gross (2017 - 2024)
SciSparc (SPRC) posted Loans - Gross of $10.5 million for Q2 2024, down 6.26% sequentially from $11.2 million in Q4 2023, and up 5.96% YoY from $9.9 million in Q3 2023.
SciSparc (SPRC) Loans - Gross (2017 - 2024) Analysis & Trends
SciSparc has reported Loans - Gross for 7 years, with the latest figure at $10.5 million in Q2 2024.
- Quarterly Loans - Gross rose 5.96% year-over-year to $10.5 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $10.5 million (up 5.96% YoY) and the FY2023 annual result came in at $11.2 million, changed N/A from the prior year.
- Loans - Gross slipped to $10.5 million in Q2 2024 per SPRC's latest filing, from $11.2 million in the prior quarter.
- Over five years, Loans - Gross peaked at $11.2 million in Q4 2023 and troughed at $1.6 million in Q2 2020.
- A 4-year average of $7.3 million and a median of $9.1 million in 2021 frame the typical range for Loans - Gross.
- The sharpest annual moves came in 2020 and 2021: Loans - Gross decreased 28.31% in 2020, then surged 423.67% in 2021.
- Over 4 years, Loans - Gross stood at $2.6 million in 2020, then surged by 225.73% to $8.3 million in 2021, then jumped by 34.04% to $11.2 million in 2023, then slipped by 6.26% to $10.5 million in 2024.
- According to Business Quant data, Loans - Gross over the past three periods registered $10.5 million, $11.2 million, and $9.9 million for Q2 2024, Q4 2023, and Q2 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Loans - Gross (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | SciSparc | 836,385.99 | 836,385.99 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 10.48 Mn |
| Dec 31, 2023 | 11.18 Mn |
| Jun 30, 2023 | 9.89 Mn |
| Jun 30, 2021 | 8.34 Mn |
| Dec 31, 2020 | 2.56 Mn |
| Jun 30, 2020 | 1.59 Mn |
| Dec 31, 2019 | 1.15 Mn |
| Jun 30, 2019 | 2.22 Mn |
| Dec 31, 2018 | 4.56 Mn |
| Sep 30, 2018 | 5.06 Mn |
| Jun 30, 2018 | 6.39 Mn |
| Mar 31, 2018 | 7.94 Mn |
| Dec 31, 2017 | 9.57 Mn |
| Sep 30, 2017 | 10.99 Mn |
| Jun 30, 2017 | 12.06 Mn |